SCHEMBL7860414

SCHEMBL7860414

CCCCC(=[NH+][O-])c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
PTGS1 P23219 1/20 0.51
SLC6A2 P23975 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTGS2 P35354 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MAOB P27338 1/20 0.51
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
NCOR2 Q9Y618 1/20 0.49
PARP10 Q53GL7 1/20 0.48
EGFR P00533 2/20 0.47
SRD5A2 P31213 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39274 0.81 CES2 (0.55) PTGS2ALDH1A1
SCHEMBL3734266 0.77 HSD17B3 (0.56) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL5238958 0.76 LTA4H (0.66) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL584524 0.75 EGFR (0.59) MAOBNR4A1NR4A2NR4A3HDAC3
SCHEMBL8412560 0.75 CES2 (0.57) PTGS2
SCHEMBL7867841 0.73 MAOB (0.55) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL30539400 0.73 LTA4H (0.68) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL27819250 0.73 HDAC1 (0.47) LMNAPTGS1PTGS2HDAC3HDAC1
SCHEMBL4152328 0.73 EGFR (0.72) MAOBNR4A1NR4A2NR4A3HDAC3
Tetradecane SCHEMBL28375680 0.72 SLC6A2 (0.57) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077694-A1 ARYL NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-02-28 EP claimed
WO-1999059576-A1 ARYL NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-25 WO claimed